Bayer Income After Taxes 2010-2024 | BAYRY
Bayer income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Bayer Annual Income After Taxes
(Millions of US $) |
| 2023 |
$-3,184 |
| 2022 |
$4,389 |
| 2021 |
$1,209 |
| 2020 |
$-17,775 |
| 2019 |
$2,722 |
| 2018 |
$2,021 |
| 2017 |
$3,671 |
| 2016 |
$5,044 |
| 2015 |
$4,462 |
| 2014 |
$4,577 |
| 2013 |
$4,232 |
| 2012 |
$3,210 |
| 2011 |
$3,443 |
| 2010 |
$1,740 |
| 2009 |
$1,895 |
Bayer Quarterly Income After Taxes
(Millions of US $) |
| 2024-06-30 |
$-2,034 |
| 2024-03-31 |
$2,174 |
| 2023-12-31 |
$1,515 |
| 2023-09-30 |
$-4,982 |
| 2023-06-30 |
$-2,060 |
| 2023-03-31 |
$2,342 |
| 2022-12-31 |
$444 |
| 2022-09-30 |
$556 |
| 2022-06-30 |
$-308 |
| 2022-03-31 |
$3,697 |
| 2021-12-31 |
$1,388 |
| 2021-09-30 |
$106 |
| 2021-06-30 |
$-2,805 |
| 2021-03-31 |
$2,520 |
| 2020-12-31 |
$304 |
| 2020-09-30 |
$-9,007 |
| 2020-06-30 |
$-10,582 |
| 2020-03-31 |
$1,509 |
| 2019-12-31 |
$-253 |
| 2019-09-30 |
$1,115 |
| 2019-06-30 |
$455 |
| 2019-03-31 |
$1,404 |
| 2018-12-31 |
$-4,706 |
| 2018-09-30 |
$3,365 |
| 2018-06-30 |
$970 |
| 2018-03-31 |
$2,392 |
| 2017-12-31 |
$-331 |
| 2017-09-30 |
$909 |
| 2017-06-30 |
$1,462 |
| 2017-03-31 |
$1,632 |
| 2016-12-31 |
$412 |
| 2016-09-30 |
$1,357 |
| 2016-06-30 |
$1,574 |
| 2016-03-31 |
$1,701 |
| 2015-12-31 |
$622 |
| 2015-09-30 |
$1,100 |
| 2015-06-30 |
$1,262 |
| 2015-03-31 |
$1,477 |
| 2014-12-31 |
$208 |
| 2014-09-30 |
$1,105 |
| 2014-06-30 |
$1,310 |
| 2014-03-31 |
$1,953 |
| 2013-12-31 |
$617 |
| 2013-09-30 |
$978 |
| 2013-06-30 |
$1,102 |
| 2013-03-31 |
$1,535 |
| 2012-12-31 |
$523 |
| 2012-09-30 |
$668 |
| 2012-06-30 |
$641 |
| 2012-03-31 |
$1,378 |
| 2011-12-31 |
$521 |
| 2011-09-30 |
$915 |
| 2011-06-30 |
$1,073 |
| 2011-03-31 |
$934 |
| 2010-12-31 |
$-258 |
| 2010-09-30 |
$368 |
| 2010-06-30 |
$669 |
| 2010-03-31 |
$962 |
| 2009-12-31 |
$263 |
| 2009-09-30 |
$356 |
| 2009-06-30 |
$722 |
| 2009-03-31 |
$555 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$0.000B |
$51.553B |
|
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
|
